跳至主要内容
临床试验/ITMCTR1900002389
ITMCTR1900002389尚未招募未知

Multicenter prospective cohort study for the prevention and treatment of hydrocephalus after acute cerebral hemorrhage with traditional Chinese medicine

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (Sichuan Traditional Chinese Medicine Hospital)0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
40 至 75(—)
性别
All

入选标准

  • (1) The first time onset cerebral hemorrhage;
  • (2) Meet the diagnostic criteria for cerebral hemorrhage, and the GCS score is >4 points;
  • (3) Aged 40 and 75 years old;
  • (4) Agree to participate in the trial and sign the informed consent form.

排除标准

  • (1) The patient's cerebral hemorrhage is caused by brain tumor, brain trauma, blood disease (secondary to anticoagulant and thrombolytic therapy);
  • (2) with a mixed stroke or cerebral hemorrhage with severe bleeding needs to surgery;
  • (3) The clinical manifestations of cerebral palsy, including the disappearance of ipsilateral pupillary reflexes and other third pairs of cranial nerve paralysis;
  • (4) with pulmonary heart disease, unstable angina or acute myocardial infarction within 6 months;
  • (5) with neurological deficits (mRS>2) before the onset of AICH;
  • (6) Accompanied by severe cardiac insufficiency (NYHA cardiac function classification III-IV);
  • (7) Accompanied by severe hepatic insufficiency (the liver function test results exceed 2 times the upper limit of the normal range);
  • (8) Accompanied by severe renal insufficiency (the serum creatinine is more than twice the upper limit of the normal range);
  • (9) Active gastrointestinal bleeding occurs after the onset of AICH in patients;
  • (10) The patient has a heavier blood system or other systemic underlying disease;
  • (11) The patient is in a state of pregnancy or breastfeeding, or has a severe allergic disease or is allergic to multiple drugs;
  • (12) The patient has other diseases that cause his neurological deficit, or join the study to aggravate his condition;
  • (13) The patient has participated in other clinical trials in the past 3 months;
  • (14) Patients without malignant tumors and receiving radiotherapy and chemotherapy

研究者

发起方
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (Sichuan Traditional Chinese Medicine Hospital)

相似试验